Max Healthcare Q4 FY26 Revenue at ₹2,664 Cr (+10% YoY), PAT at ₹387 Cr
Max Healthcare's Q4 FY26 revenue rose 10% YoY to ₹2,664 Cr, with Operating EBITDA at ₹682 Cr (+8% YoY) and PAT at ₹387 Cr (+3% YoY). For FY26, revenue grew 16% to ₹10,538 Cr. The company completed the acquisition of Kalinga Hospital Ltd. and approved a ₹1,400 Cr greenfield hospital in Lucknow.
The announcement includes robust financial performance, significant capital expenditure for future growth, and a strategic acquisition, all of which are material to the company's future prospects and investor outlook.
The company reported strong year-on-year growth in revenue and EBITDA, along with strategic acquisitions and significant greenfield investments, indicating a positive outlook.
Max Healthcare Institute Limited announced its financial and operating results for the fourth quarter and financial year ended March 31, 2026. The company reported a gross revenue of ₹2,664 Cr for Q4 FY26, a year-on-year growth of 10%. Network Operating EBITDA stood at ₹682 Cr, an 8% increase YoY. Profit After Tax (PAT) for the network was ₹387 Cr, a 3% growth YoY. For the full financial year FY26, the network gross revenue was ₹10,538 Cr, a 16% growth YoY, and Operating EBITDA was ₹2,638 Cr, a 14% growth YoY. The company also highlighted the phased commissioning of nearly 20% additional brownfield capacity and the rollout of new towers. The acquisition of a controlling stake of 58.28% in Kalinga Hospital Ltd. (KHL) was consummated on May 18, 2026. Furthermore, the Board approved an investment of approximately ₹1,400 Cr for the construction of a 712-bed greenfield hospital in Lucknow, expected to be commissioned in FY30. Max Lab reported revenue of ₹52 Cr, a 14% YoY growth, and Max@Home reported ₹73 Cr, a 30% YoY growth.
What to do with a filing like this
Max Healthcare Institute Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Max Healthcare Institute Limited. Read the original for the full detail.